← FDA Drug Approvals (Drugs@FDA)

DURYSTA

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2020-03-04

Drug application

FDA Application #

NDA211911

Application type

New Drug Application

Brand name

DURYSTA

Generic name

BIMATOPROST

Active ingredients

BIMATOPROST

Dosage form

IMPLANT

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

ABBVIE

Manufacturer

Allergan, Inc.

First approval

2020-03-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown